









Markets
/
Stocks
/
nasdaq-mgrx
/

Mangoceuticals Inc

MGRX

2.250USD

+0.030+1.35%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

23.95MMarket Cap

LossP/E TTM



Mangoceuticals Inc

2.250

+0.030+1.35%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

20.34%-1.26M

-129.51%-2.27M

33.47%-1.13M

31.85%-1.17M

11.34%-1.58M

45.24%-991.13K

-161.37%-1.70M

-184.96%-1.71M

---1.78M

---1.81M

---649.56K

---600.35K

Net income from continuing operations

-126.48%-5.42M

-104.40%-4.84M

24.12%-1.95M

-11.13%-2.00M

-4.70%-2.39M

7.55%-2.37M

-281.21%-2.57M

-84.50%-1.80M

---2.28M

---2.56M

---673.65K

---975.32K

Operating gains losses

25991.54%836.23K

6567.61%414.99K

11373.34%721.79K

-95.99%252.00

-48.51%3.21K

2.33%6.22K

62.85%6.29K

--6.29K

--6.22K

--6.08K

--3.86K

----

Other non-cash items

207.94%3.18M

365.43%1.94M

-106.49%-23.29K

726.53%700.48K

166.43%1.03M

-40.50%416.50K

452.71%358.90K

-68.02%84.75K

--387.00K

--700.00K

---101.76K

--265.00K

Change in working capital

133.52%97.07K

-82.50%160.24K

-8.53%69.55K

135.23%24.37K

-619.48%-289.57K

4441.71%915.80K

35.98%76.03K

-11.48%-69.17K

--55.74K

---21.09K

--55.92K

---62.05K

-Change in inventory

----

-271.69%-5.29K

-57.87%806.00

101.84%433.00

--4.05K

--3.08K

--1.91K

---23.49K

----

-Change in prepaid expenses

77.99%83.21K

-9325.50%-83.21K

-100.00%0.00

142.06%13.30K

317.60%46.75K

104.62%902.00

-9.80%23.43K

16.17%-31.62K

---21.48K

---19.53K

--25.98K

---37.72K

-Change in payables and accrued expense

127.03%89.82K

-62.57%340.68K

61.57%83.54K

185.82%35.31K

-434.27%-332.30K

31714.45%910.18K

--51.71K

---41.15K

--99.41K

---2.88K

----

-Change in other current assets

8.95%16.10K

8.63%15.72K

8.81%15.42K

10.00%15.10K

7.44%14.78K

8.59%14.47K

107.41%14.17K

--13.73K

--13.76K

--13.32K

---191.18K

----

-Change in other current liabilities

-2871.30%-104.47K

-6051.31%-95.70K

-372.27%-7.58K

-1261.78%-24.11K

-306.70%-3.52K

-5.80%1.61K

-178.45%-1.60K

209.24%2.08K

--1.70K

--1.71K

--2.05K

--671.00

Cash from non-recurring investing activities

Cash from operating activities

20.34%-1.26M

-129.51%-2.27M

33.47%-1.13M

31.85%-1.17M

11.34%-1.58M

45.24%-991.13K

-161.37%-1.70M

-184.96%-1.71M

---1.78M

---1.81M

---649.56K

---600.35K

Investing cash flow

Net cash from continuing investing activities

----

--0.00

---65.00K

-100.00%0.00

--0.00

--3.52K

--40.57K

--2.53K

Capital expenditures

----

-100.00%0.00

--0.00

--3.52K

--40.57K

--2.53K

Net cash flow from disposal of fixed assets

----

--0.00

---65.00K

-100.00%0.00

--0.00

--3.52K

--40.57K

--2.53K

Cash from non-current investing activities

Net cash flow from investing activities

----

--0.00

--65.00K

100.00%0.00

--0.00

---3.52K

---40.57K

---2.53K

Financing cash flow

Cash flow from continuous financing activities

-35.58%1.28M

754.21%2.29M

-6.46%1.12M

--750.00K

112.58%1.99M

-94.56%267.50K

140.24%1.20M

-100.00%0.00

--935.30K

--4.92M

--499.50K

--1.48M

Net cash flow from debt Issuance/repayment

500.00%600.00K

----

---37.50K

--0.00

212.11%100.00K

211.81%87.50K

--0.00

100.00%0.00

---89.20K

---78.26K

--0.00

---13.39K

Net cash flow from common stock issuance/repurchase

10.95%430.79K

263.89%655.00K

-36.67%760.00K

--0.00

--388.27K

-96.40%180.00K

140.24%1.20M

-100.00%0.00

--0.00

--5.00M

--499.50K

--1.50M

Net cash flow from preferred stock issuance/repurchase

-170.00%-1.05M

--1.15M

--400.00K

--750.00K

--1.50M

----

Proceeds from issuance of warrants

--1.30M

--480.00K

----

--0.00

--1.02M

----

Net cash flow from other financing activities

----

---11.61K

Net cash from non-recurrent financing activities

Net cash from financing activities

-35.58%1.28M

754.21%2.29M

-6.46%1.12M

--750.00K

112.58%1.99M

-94.56%267.50K

140.24%1.20M

-100.00%0.00

--935.30K

--4.92M

--499.50K

--1.48M

Net cash flow

Beginning cash balance

399.81%76.50K

-92.06%58.65K

-94.02%73.91K

-83.37%490.24K

-99.60%15.30K

8.22%739.01K

--1.24M

--2.95M

--3.79M

--682.86K

--0.00

Current period cash flow changes

-94.84%24.52K

102.47%17.84K

96.93%-15.26K

75.66%-416.33K

156.29%474.94K

-123.28%-723.70K

-161.10%-497.74K

-296.05%-1.71M

---843.72K

--3.11M

---190.63K

--872.62K

Effect of exchange rate changes

117.06%187.00

10991.43%7.62K

---8.18K

---497.00

---1.10K

---70.00

----

Ending cash balance

-79.39%101.02K

399.81%76.50K

-92.06%58.65K

-94.02%73.91K

-83.37%490.24K

-99.60%15.30K

487.66%739.01K

41.73%1.24M

--2.95M

--3.79M

---190.63K

--872.62K

Free cash flow

----

33.47%-1.13M

31.85%-1.17M

11.34%-1.58M

45.34%-991.13K

-146.00%-1.70M

-183.76%-1.71M

---1.78M

---1.81M

---690.13K

---602.88K

Currency unit

USD

Audit opinions

KeyAI

